This free, 90-minute CME credit activity is brought to you in partnership between CMEOutfitters and HealthMinds. The activity was premiered on Wednesday, May 12, 2021 and is designated with Accreditation Council for Continuing Medical Education (ACCME) credits of maximum of 1.5 AMA PRA Category 1 CreditTM
The novel SARS-CoV-2 virus caused the rapid global spread of COVID-19, and while coronavirus is often mild and self-limiting, approximately 10% of mild SARS-CoV-2 infections progress to severe symptoms, including respiratory distress syndrome, and up to 20% of symptomatic patients develop critical disease with clinical complications including pneumonia and hyper- inflammation. Several repurposed drugs have been used to treat patients hospitalized with serious COVID-19 disease, with neutralizing monoclonal antibodies (nAbs) being one of the first therapies offered by the FDA. But despite promising results, the demand for treatment for mild-to-moderate COVID-19 has not met expectations, as many health care providers may not be familiar with or aware that preventative treatments are available for mild-to-moderate COVID-19.
This activity on early intervention treatments following diagnosis of COVID-19 as a way to reduce progression to severe disease will include the latest data on the efficacy and safety of nAb therapies and strategies for addressing knowledge and practice barriers to improve patient access to these therapies.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www. lillygrantoffice.com
Physicians, PAs, nurse practitioners, nurses, infusion center nurses, and pharmacists
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC and CME Master. CME Outfitters, LLC is accredited by the ACCME to provide continuing medical education for physicians.
CME Outfitters, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.